Varisco V, et al. J Rheumatol.2016;doi:10.3899/jrheum.151105. Patients with rheumatoid arthritis and resolved hepatitis B virus infection who underwent treatment with rituximab did not experience reactivation of the infection, according to results of a multicenter Italian study. Researchers retrospectively studied data … Continue reading →